No Data
No Data
Sernova Biotherapeutics Inc: INTERIM MDA EN
Sernova Biotherapeutics Inc: INTERIM FINANCIAL STATEMENTSREPORT EN
Sernova Biotherapeutics Appoints Pericles Calias, Ph.D. as Chief Development Officer and Head of R&D
Sernova Biotherapeutics Secures $1 Million Convertible Debt Financing
Sernova Biotherapeutics Receives FDA Clearance for IND Application for Its Cell Pouch Bio-hybrid Organ With Autograft Thyroid Cells in Patients With Hypothyroidism
Sernova Announces Appointment of Ross Haghighat as Chair of the Board and a Change of Name to Sernova Biotherapeutics